Quanta BioSciences

Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational, and life science research. Based in Beverly, Massachusetts, Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers. Quantabio has a rich history of creating market-leading PCR & qPCR reagents. We developed the Qscript lyo 1-Step and sparQ Fast Library Quant Kit. Quantabio continued to pioneer with the repliQa HiFi ToughMix, AccuStart Long Range SuperMix, qScript 1-Step Virus ToughMix, and sparQ Universal Library Quant Kit. Quantabio offers complete library prep solutions for Illumina NGS platforms. Our team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical cloning, PCR, qPCR, and Next-Generation Sequencing (NGS) applications. In our early days, we developed Invitrogen’s SuperScript One-Step RT-PCR Kits, Platinum Taq, and Bio-Rad’s iScript and iQ/iTaq Supermixes.

Quantoom Biosciences is reinventing mRNA production by developing the platform Ntensify that encompasses DNA amplification and RNA manufacturing and formulation. Quantoom entered into a strategic collaboration to build an advanced, small footprint technology platform for the production of affordable RNA-based therapies, that can be used either within existing facilities or rapidly deployed to areas of urgent need. Quantoom acquires the French biotech, SynHelix, who has developed a technology that is an alternative to DNA amplification using bacteria. The company was renamed Quantoom Research France and is focusing on integrating a “new generation DNA bioreactor” that will provide unparalleled benefits in productivity and cost saving, both for R&D and production needs. We are on a mission to remove the barriers to making mRNA-based vaccines & therapeutics, at every stage from sequence up to mass production. At Quantoom Biosciences, we are bringing radical innovation to the way mRNA is produced in any research lab, biotech biopharma or CDMO. We are a team of scientists, engineers and clinicians committed to solving some of the biggest DNA and RNA production challenges facing vaccines and therapeutics, by delivering greater access and autonomy to mRNA technology. The platform includes critical reagents supply, to enable RNA assembly from sequence to large-scale production.

In tandem with Quantigen's range of preclinical and clinical research review services, Versiti's specialty CRO provides comprehensive, flexible services that range from IRB review through central laboratory services, biologistics, project management and more to support your unique study needs through every phase. Quantigen specializes in sample-to-answer method development and validation across a broad array of applications. Quantigen works with its non-profit partners to develop and deploy critical tools for infectious disease testing in lower- and middle-income countries. We are approved for patient diagnostic testing in all fifty States, including specific offerings through the State of New York (PFI:9406) and California (State ID: CDS-00800560). Quantigen also maintains ISO 15189:2012 accreditation by A2LA (Certificate # 4842.01), demonstrating our dedication to the highest standards of data quality. For more than a decade, we have leveraged our expertise in molecular biology, biotechnology, and regulatory oversight to design customized, cost-effective workflows for our clients in three core areas:. From product testing and applications development, to clinical trials management and medical device design, Quantigen goes the extra mile for its many industry partners. Collaborations between academic institutions and Quantigen provide our scientists with the opportunity to extend the boundaries of basic and clinical research.

Quantimetrix designs, develops, and manufactures laboratory quality products at our headquarters in Redondo Beach, California. We are leaders in the field of liquid-stable quality control products, having pioneered these innovations more than 40 years ago. Quantimetrix team members embody the iQi core values: Integrity, Quality, & Innovation. We are proud that many of our employees have been part of the Quantimetrix family for more than 20 years, bringing a high level of experience and expertise to every aspect of our operations. Quantimetrix customers come from hospitals, doctor’s offices, reference labs, and research facilities. Our products are compliant with 98/79/EC – the European Union’s In Vitro Diagnostic Medical Device Directive. Quantimetrix designs, develops and manufactures its products in the United States of America. We strive to maintain the highest standards in our products and services and are always looking for ways to improve the customer experience.

Established in 2002, QA-Bio is dedicated to supplying the biopharmaceutical manufacturing community with the tools required for the analysis of glycans. Our products are used in FDA & EMA approved procedures by biopharmaceutical companies throughout the world. We optimize the chemistries, materials, manufacturing and storage procedures of our kits and reagents to maintain the highest performance standards for accuracy and reproducibility.

The Q-bios GmbH was founded in 2009 to provide products and services for the life sciences including the biotechnology, pharmaceutical and diagnostic industry. Q-bios’ expertise is the production of recombinant peptides, antigens and other proteins, which we offer to other companies in bulk amounts and as OEM. Q-bios GmbH is your specialist for recombinant protein and enzyme production. We produce various DNA polymerases and PCR mastermixes – for routine applications or custom designed specifically for your needs. Our purpose: Providing the best products and consultancy for your goals in the life sciences. Aside from this, we specialized on the production and distribution of PCR related reagents. Our PCR products can be purchased by companies in large quantities tailored to their needs. PCR products are also marketed for end consumers by distributors in different countries.